← Leaderboards
Nancy L Bartlett
Washington University
$8,628,353
Attributed
$22,023,116
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,023,116 · 6
By mechanism
U10$11,961,969 · 2
UG1$9,185,221 · 1
P30$875,926 · 2
M01$0 · 1
Top collaborators
- Barry A. Siegel14 shared
- Clifford Grant Robinson10 shared
- Benjamin D Kozower9 shared
- Premal Harish Thaker8 shared
- David G Mutch6 shared
- Bryan F Meyers5 shared
- Jeff M Michalski4 shared
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsResearch PersonnelWashingtonMemberCancer CenterUniversitiesClinical ResearchMalignant NeoplasmsAmerican College Of Radiology Imaging NetworkSiteInstitutionCommunicationThoracic OncologyAreaProtocols DocumentationMissionCollaborationsIllinoisDesignMissouriOncologyMalignant Breast NeoplasmPhysiciansComprehensive Cancer Center
Grant awards (38)
Washington University/Siteman Cancer Center Lead Academic Site$1,239,849
UG1 · FY2025 · CA · contact PI
Washington University/Siteman Cancer Center Lead Academic Site$1,241,704
UG1 · FY2024 · CA · contact PI
Washington University/Siteman Cancer Center Lead Academic Site$1,307,056
UG1 · FY2023 · CA · contact PI
Washington University/Siteman Cancer Center Lead Academic Site$1,307,004
UG1 · FY2022 · CA · contact PI
Washington University/Siteman Cancer Center Lead Academic Site$1,407,055
UG1 · FY2021 · CA · contact PI
Washington University/Siteman Cancer Center Lead Academic Site$70,000
UG1 · FY2021 · CA · contact PI
Washington University/Siteman Cancer Center Lead Academic Site$1,306,833
UG1 · FY2020 · CA · contact PI
Washington University/Siteman Cancer Center Lead Academic Site$1,305,720
UG1 · FY2019 · CA · contact PI
Washington University/ Siteman Cancer Center Lead Academic Site$1,394,352
U10 · FY2018 · CA · contact PI
Washington University/ Siteman Cancer Center Lead Academic Site$1,316,888
U10 · FY2017 · CA · contact PI
Washington University/ Siteman Cancer Center Lead Academic Site$1,649,280
U10 · FY2016 · CA · contact PI
Washington University/ Siteman Cancer Center Lead Academic Site$100,000
U10 · FY2016 · CA · contact PI
Washington University/ Siteman Cancer Center Lead Academic Site$1,549,280
U10 · FY2015 · CA · contact PI
Washington University/ Siteman Cancer Center Lead Academic Site$1,548,433
U10 · FY2014 · CA · contact PI
Data and Safety Monitoring$166,677
P30 · FY2014 · CA · contact PI
WUMC Cancer and Leukemia Group B$320,126
U10 · FY2013 · CA · contact PI
Data and Safety Monitoring$164,499
P30 · FY2013 · CA · contact PI
WUMC Cancer and Leukemia Group B$349,322
U10 · FY2012 · CA · contact PI
Data and Safety Monitoring$171,659
P30 · FY2012 · CA · contact PI
Data and Safety Monitoring$2,777
P30 · FY2012 · CA · contact PI
WUMC Cancer and Leukemia Group B$330,937
U10 · FY2011 · CA · contact PI
Data and Safety Monitoring$119,388
P30 · FY2011 · CA · contact PI
WUMC Cancer and Leukemia Group B$360,039
U10 · FY2010 · CA · contact PI
Data and Safety Monitoring$126,099
P30 · FY2010 · CA · contact PI
WUMC Cancer and Leukemia Group B$345,040
U10 · FY2009 · CA · contact PI
WUMC-Cancer and Leukemia Group B$334,932
U10 · FY2008 · CA · contact PI
WUMC-Cancer and Leukemia Group B$334,381
U10 · FY2007 · CA · contact PI
WUMC-Cancer and Leukemia Group B$327,611
U10 · FY2006 · CA · contact PI
WUMC-Cancer and Leukemia Group B$327,143
U10 · FY2005 · CA
WUMC-Cancer and Leukemia Group B$325,316
U10 · FY2004 · CA
Quality Assurance and Safety Monitoring$124,827
P30 · FY2004 · CA
WUMC-Cancer and Leukemia Group B$305,489
U10 · FY2003 · CA
WUSM CANCER AND LEUKEMIA GROUP B$265,433
U10 · FY2002 · CA
24hr infusion of HMR1275 in fludarabine--B cell leukemia$0
M01 · FY2002 · RR
WUSM CANCER AND LEUKEMIA GROUP B$254,695
U10 · FY2001 · CA
24hr infusion of HMR1275 in fludarabine--B cell leukemia$0
M01 · FY2001 · RR
WUSM CANCER AND LEUKEMIA GROUP B$223,272
U10 · FY2000 · CA
24hr infusion of HMR1275 in fludarabine--B cell leukemia$0
M01 · FY2000 · RR